These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32849581)

  • 1. New MoDC-Targeting TNF Fusion Proteins Enhance Cyclic Di-GMP Vaccine Adjuvanticity in Middle-Aged and Aged Mice.
    Gogoi H; Mansouri S; Katikaneni DS; Jin L
    Front Immunol; 2020; 11():1674. PubMed ID: 32849581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immature lung TNFR2
    Mansouri S; Patel S; Katikaneni DS; Blaauboer SM; Wang W; Schattgen S; Fitzgerald K; Jin L
    Mucosal Immunol; 2019 Jan; 12(1):277-289. PubMed ID: 30327534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte-Derived Dendritic Cells (moDCs) Differentiate into Bcl6
    Mansouri S; Katikaneni DS; Gogoi H; Jin L
    J Immunol; 2021 May; 206(9):2233-2245. PubMed ID: 33879579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MPYS/STING-mediated TNF-α, not type I IFN, is essential for the mucosal adjuvant activity of (3'-5')-cyclic-di-guanosine-monophosphate in vivo.
    Blaauboer SM; Gabrielle VD; Jin L
    J Immunol; 2014 Jan; 192(1):492-502. PubMed ID: 24307739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice.
    Madhun AS; Haaheim LR; Nøstbakken JK; Ebensen T; Chichester J; Yusibov V; Guzman CA; Cox RJ
    Vaccine; 2011 Jul; 29(31):4973-82. PubMed ID: 21600260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3',5'-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection.
    Yan H; KuoLee R; Tram K; Qiu H; Zhang J; Patel GB; Chen W
    Biochem Biophys Res Commun; 2009 Sep; 387(3):581-4. PubMed ID: 19615973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against
    Jiang W; Wang X; Su Y; Cai L; Li J; Liang J; Gu Q; Sun M; Shi L
    Front Immunol; 2022; 13():878832. PubMed ID: 35493458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities.
    Gray PM; Forrest G; Wisniewski T; Porter G; Freed DC; DeMartino JA; Zaller DM; Guo Z; Leone J; Fu TM; Vora KA
    Cell Immunol; 2012; 278(1-2):113-9. PubMed ID: 23121983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses.
    Kamath AT; Mastelic B; Christensen D; Rochat AF; Agger EM; Pinschewer DD; Andersen P; Lambert PH; Siegrist CA
    J Immunol; 2012 May; 188(10):4828-37. PubMed ID: 22504654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant.
    Ebensen T; Libanova R; Schulze K; Yevsa T; Morr M; Guzmán CA
    Vaccine; 2011 Jul; 29(32):5210-20. PubMed ID: 21619907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenteric CD103
    Zhao H; Yang J; Qian Q; Wu M; Li M; Xu W
    Front Immunol; 2018; 9():2986. PubMed ID: 30619341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
    Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
    Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG.
    Yildiz S; Alpdundar E; Gungor B; Kahraman T; Bayyurt B; Gursel I; Gursel M
    Eur J Immunol; 2015 Apr; 45(4):1170-9. PubMed ID: 25581346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.
    Bielinska AU; O'Konek JJ; Janczak KW; Baker JR
    Vaccine; 2016 Jul; 34(34):4017-24. PubMed ID: 27317451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Mucosal and Systemic Vaccine Responses by Cyclic di-GMP (CDG)-adjuvanted Protein Subunit Vaccines.
    Mansouri S; Jin L
    Bio Protoc; 2019 Apr; 9(8):e3217. PubMed ID: 33655008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic GMP-AMP displays mucosal adjuvant activity in mice.
    Škrnjug I; Guzmán CA; Rueckert C
    PLoS One; 2014; 9(10):e110150. PubMed ID: 25295996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes.
    Mortensen R; Christensen D; Hansen LB; Christensen JP; Andersen P; Dietrich J
    PLoS One; 2017; 12(4):e0175707. PubMed ID: 28414746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-α promotes survival and phenotypic maturation of poly(I:C)-treated dendritic cells but impairs their Th1 and Th17 polarizing capability.
    Thorne A; Tomić S; Pavlović B; Mihajlović D; Džopalić T; Čolić M
    Cytotherapy; 2015 May; 17(5):633-46. PubMed ID: 25559144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
    Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant.
    Ebensen T; Schulze K; Riese P; Morr M; Guzmán CA
    Clin Vaccine Immunol; 2007 Aug; 14(8):952-8. PubMed ID: 17567766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.